Boehringer Ingelheim’s Hernexeos FDA Approved for First-Line HER2-Mutant NSCLC

… all subscription options. Filed under. Precision Oncology · Regulatory News & FDA Approvals · FDA · FDA clearance · regulatory approval · Boehringer- …